merged_cancer-screening-tests-cost.txt
<question_number>1</question_number>
<answer>vastly improved treatment for colon cancer</answer>
<question_number>2</question_number>
<answer>studies show screening rarely extends life or markedly lowers death rates</answer>
<question_number>3</question_number>
<answer>death rates kept falling linearly and were not sped up by more screening</answer>
<question_number>4</question_number>
<answer>screening’s mortality benefit is so small that only huge trials can detect it</answer>
<question_number>5</question_number>
<answer>just a 1‑percentage‑point absolute risk drop (3 % to 2 %) despite the 33 % figure</answer>
<question_number>6</question_number>
<answer>effective treatments reduce deaths, diminishing the added value of screening</answer>
<question_number>7</question_number>
<answer>diet changes could lower colon cancer risk, helping cut deaths without screening</answer>
<question_number>8</question_number>
<answer>widespread, costly screening yields little survival benefit or death‑rate reduction</answer>
<question_number>9</question_number>
<answer>supporters credit screening for falling deaths, yet data show declines happened without extra help from more screening</answer>
<question_number>10</question_number>
<answer>by pointing to improved treatments, dietary shifts and other exposure changes as main drivers of the decline</answer>